“So far, as legal challenges are concerned, we’re not scared of them,” Howman said. “The system is robust and we have confidence in it.”
Tygart responded in a statement: “Any suggestion that the Usada process is unfair is a blatant distortion of the truth. The truth is this arbitration process is grounded in a federal statute and contains all of the safeguards to ensure a fair hearing.”
Its review board — which is where Armstrong’s case is headed now — is like a grand jury, but does not have any investigative or subpoena power. It consists of technical, legal and medical experts who examine the evidence and see if the case is strong enough for the athlete to charged with breaking antidoping rules.
Armstrong had 10 days, until June 22, to file a written submission to that review board. If he had failed a drug test, he would have received the laboratory documentation of that failed test. But he did not, according to a letter the antidoping agency sent to him last week that listed the charges against him.
The agency said only that data from blood collections obtained by the International Cycling Union from Armstrong in 2009 and 2010 is “fully consistent with blood manipulation including EPO use and/or blood transfusions.”
If the review board finds enough evidence to charge Armstrong, then the antidoping agency will charge him with a doping violation. If he does not accept the charges, the next step for him would be to proceed to a hearing, which is mandated by the Ted Stevens Olympic and Amateur Sports Act.
A three-person arbitration panel that would eventually rule on the case is convened in advance of that hearing. That panel determines when the antidoping agency gives Armstrong the evidence it has against him, the antidoping agency said.
But to get to that point might take a while.
http://www.nytimes.com/2012/06/20/s...e-in-lance-armstrong-case.html?pagewanted=all